How Global Regulatory Trends Are Quietly Shaping FDA Reviews

Global regulators are converging on how they evaluate AI and software in medical devices. The IMDRF’s 2025 guidance, FDA-EMA alignment, and new international standards are redefining what compliance means—shaping U.S. submissions and timelines for global startups entering the MedTech market.